The Queen’s Univ professor whose previous research led to the formation of Neurochem Inc is the driving scientific force behind the creation of AtheroChem Inc. The cholesterol research of Dr Robert Kisilevsky, a professor of anatomic pathology, is deemed to possess considerable scientific and commercial potential for reversing the development of atherosclerosis, the primary cause of coronary heart disease.